These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 21333660)
21. Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviors. Pobbe RL; Zangrossi H; Blanchard DC; Blanchard RJ Eur Neuropsychopharmacol; 2011 Apr; 21(4):306-15. PubMed ID: 20570114 [TBL] [Abstract][Full Text] [Related]
22. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei. Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218 [TBL] [Abstract][Full Text] [Related]
23. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue. Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351 [TBL] [Abstract][Full Text] [Related]
24. Repeated administration of the 5-HT(1B) receptor antagonist SB-224289 blocks the desensitisation of 5-HT(1B) autoreceptors induced by fluoxetine in rat frontal cortex. Shalom G; Gur E; Van de Kar LD; Newman ME Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):84-90. PubMed ID: 15309378 [TBL] [Abstract][Full Text] [Related]
25. Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus. Bambico FR; Cassano T; Dominguez-Lopez S; Katz N; Walker CD; Piomelli D; Gobbi G Neuropsychopharmacology; 2010 Sep; 35(10):2083-100. PubMed ID: 20571484 [TBL] [Abstract][Full Text] [Related]
26. Regulation of central synaptic transmission by 5-HT(1B) auto- and heteroreceptors. Morikawa H; Manzoni OJ; Crabbe JC; Williams JT Mol Pharmacol; 2000 Dec; 58(6):1271-8. PubMed ID: 11093763 [TBL] [Abstract][Full Text] [Related]
27. Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT(1B) receptor knock-out mice. Malagié I; David DJ; Jolliet P; Hen R; Bourin M; Gardier AM Eur J Pharmacol; 2002 May; 443(1-3):99-104. PubMed ID: 12044798 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats. Wesołowska A; Paluchowska MH; Gołembiowska K; Chojnacka-Wójcik E J Pharm Pharmacol; 2003 Apr; 55(4):533-43. PubMed ID: 12803776 [TBL] [Abstract][Full Text] [Related]
29. Reduced 5-HT1A- and GABAB receptor function in dorsal raphé neurons upon chronic fluoxetine treatment of socially stressed rats. Cornelisse LN; Van der Harst JE; Lodder JC; Baarendse PJ; Timmerman AJ; Mansvelder HD; Spruijt BM; Brussaard AB J Neurophysiol; 2007 Jul; 98(1):196-204. PubMed ID: 17460100 [TBL] [Abstract][Full Text] [Related]
30. Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice. David DJ; Froger N; Guiard B; Przybylski C; Jego G; Boni C; Hunt SP; De Felipe C; Hamon M; Jacquot C; Gardier AM; Lanfumey L Eur J Pharmacol; 2004 May; 492(1):41-8. PubMed ID: 15145704 [TBL] [Abstract][Full Text] [Related]
32. 5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex. Malagié I; Trillat AC; Bourin M; Jacquot C; Hen R; Gardier AM J Neurochem; 2001 Feb; 76(3):865-71. PubMed ID: 11158258 [TBL] [Abstract][Full Text] [Related]
33. Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice. Deltheil T; Tanaka K; Reperant C; Hen R; David DJ; Gardier AM Int J Neuropsychopharmacol; 2009 Aug; 12(7):905-15. PubMed ID: 19236729 [TBL] [Abstract][Full Text] [Related]
34. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors. Zhang J; Huang XY; Ye ML; Luo CX; Wu HY; Hu Y; Zhou QG; Wu DL; Zhu LJ; Zhu DY J Neurosci; 2010 Feb; 30(7):2433-41. PubMed ID: 20164327 [TBL] [Abstract][Full Text] [Related]
35. Rapid reorganization of serotonin projections and antidepressant response to 5-HT1A-biased agonist NLX-101 in fluoxetine-resistant cF1ko mice. Vahid-Ansari F; Newman-Tancredi A; Fuentes-Alvarenga AF; Daigle M; Albert PR Neuropharmacology; 2024 Dec; 261():110132. PubMed ID: 39208980 [TBL] [Abstract][Full Text] [Related]
36. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus. Bermack JE; Haddjeri N; Debonnel G J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555 [TBL] [Abstract][Full Text] [Related]
37. Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knock-out mouse. Conductier G; Dusticier N; Lucas G; Côté F; Debonnel G; Daszuta A; Dumuis A; Nieoullon A; Hen R; Bockaert J; Compan V Eur J Neurosci; 2006 Aug; 24(4):1053-62. PubMed ID: 16930432 [TBL] [Abstract][Full Text] [Related]
38. Serotonin 1B autoreceptors originating in the caudal dorsal raphe nucleus reduce expression of fear and depression-like behavior. McDevitt RA; Hiroi R; Mackenzie SM; Robin NC; Cohn A; Kim JJ; Neumaier JF Biol Psychiatry; 2011 Apr; 69(8):780-7. PubMed ID: 21353664 [TBL] [Abstract][Full Text] [Related]
39. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Sharp T; Umbers V; Gartside SE Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551 [TBL] [Abstract][Full Text] [Related]
40. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse. Knobelman DA; Hen R; Blendy JA; Lucki I J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]